3 ms·
Ask HN: Are YC or anyone else funding generic drug disrupters?
Seems like an obvious choice for VC would be a generic drug company. To take a single example, even “generic” epipens costing $300 or so in the US, a new take on generic drugs feels like a strong candidate for VC funding. What am I missing?
- davismwfl 7y agoThese types of businesses are getting created and funded (just not in large quantities like tech companies), and you will not find it here on HN or really in typical VC tech circles. Medical devices and Pharmaceuticals are not easy or simple things to bring to market and you can't "hack" around the FDA to short circuit the timeframes etc. Even using approved formularies there are very detailed testing requirements which take significant amounts of time. Which leads to costs not being so inexpensive once all the research, development and market costs are calculated. Obviously I agree the $300 epipen for example is insane and although I am not sure how much can be trimmed there, I am sure it is fairly large.
- toomuchtodo 7y agoGeneric Epi alternative you can get through CVS. https://www.cvs.com/content/epipen-alternative https://www.cvs.com/content/epipen-alternative
- deleted 7y ago[deleted]
- nknealk 7y agoLook at news + stock price movement in the past 5 years on Teva and Mylan, two of the largest generic makers in the world. The outlook on the generic industry isn't great to say the least.
- muzani 7y agoYes, YC is specifically requesting for startups who can make cheaper pharmaceuticals: https://www.ycombinator.com/rfs/ https://www.ycombinator.com/rfs/
- 401kguy 7y agoCoincidentally, today Sequence Bio (YC S19) posted their Launch HN: https://news.ycombinator.com/item?id=20986079 https://news.ycombinator.com/item?id=20986079